Laparoscopic treatment of endometrial cancer: A cost-effectiveness analysis.

被引：0
|
作者：
Abaid, L. N. [1 ]
Boggess, J. [1 ]
Wu, J. [1 ]
机构：
[1] Univ N Carolina, Chapel Hill, NC 27515 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6127
引用
收藏
页码：332S / 332S
页数：1
相关论文
共 50 条
  • [21] Robotic versus laparoscopic surgery for rectal cancer and cost-effectiveness analysis
    Hottenrott, Christof
    [J]. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2011, 25 (12): : 3954 - 3956
  • [22] Cost-effectiveness analysis of laparoscopic versus open surgery in colon cancer
    Mar, Javier
    Anton-Ladislao, Ane
    Ibarrondo, Oliver
    Arrospide, Arantzazu
    Lazaro, Santiago
    Gonzalez, Nerea
    Bare, Marisa
    Callejo, Daniel
    Redondo, Maximino
    Quintana, Jose M.
    [J]. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2018, 32 (12): : 4912 - 4922
  • [23] Robotic versus laparoscopic surgery for rectal cancer and cost-effectiveness analysis
    Christof Hottenrott
    [J]. Surgical Endoscopy, 2011, 25 : 3954 - 3956
  • [24] Trastuzumab (Herceptin®) for treatment of HER2-positive metastatic breast cancer:: a cost-effectiveness analysis.
    Hornberger, J
    Foutel, V
    Kerrigan, M
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S136 - S136
  • [25] Second-line treatment of metastatic gastric cancer in the era of predictive biomarkers: A cost-effectiveness analysis.
    Lauren, Brianna
    Silver, Elisabeth
    Ingram, Myles
    Oh, Aaron
    Kumble, Lindsay
    Ostvar, Sassan
    Laszkowska, Monika
    Chu, Jacqueline N.
    Manji, Gulam Abbas
    Neugut, Alfred I.
    Hur, Chin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [26] Cost-effectiveness of new technologies for staging endometrial cancer
    D. Heller
    H. Hricak
    [J]. European Radiology, 2000, 10 : S381 - S385
  • [27] Cost-effectiveness of new technologies for staging endometrial cancer
    Heller, D
    Hricak, H
    [J]. EUROPEAN RADIOLOGY, 2000, 10 (Suppl 3) : S381 - S385
  • [28] Trastuzumab in adjuvant breast cancer therapy: A model based cost-effectiveness analysis.
    Norum, J.
    Olsen, J. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 34S - 34S
  • [29] Cost-effectiveness analysis of the treatment for intermediate risk endometrial cancer: postoperative brachytherapy vs. observation
    Fanning, J
    Hoffman, ML
    Andrews, SJ
    Harrah, AW
    Feldmeier, JJ
    [J]. GYNECOLOGIC ONCOLOGY, 2004, 93 (03) : 632 - 636
  • [30] Treatment of chronic atrial fibrillation with warfarin or aspirin: A cost-effectiveness and cost-utility analysis.
    Zarnke, KB
    Levine, MAH
    OBrien, B
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (02) : PII89 - PII89
12345